- Home
- TERN vs SAR Comparison
TERN vs SAR Comparison
Compare TERN & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- SAR
- Stock Information
- Founded
- TERN 2017
- SAR 2007
- Country
- TERN United States
- SAR United States
- Employees
- TERN N/A
- SAR N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- SAR Investment Managers
- Sector
- TERN Health Care
- SAR Finance
- Exchange
- TERN Nasdaq
- SAR Nasdaq
- Market Cap
- TERN 298.1M
- SAR 309.4M
- IPO Year
- TERN 2021
- SAR 2007
- Fundamental
- Price
- TERN $2.71
- SAR $23.33
- Analyst Decision
- TERN Buy
- SAR Buy
- Analyst Count
- TERN 5
- SAR 4
- Target Price
- TERN $18.38
- SAR $25.08
- AVG Volume (30 Days)
- TERN 1.3M
- SAR 98.8K
- Earning Date
- TERN 05-12-2025
- SAR 05-07-2025
- Dividend Yield
- TERN N/A
- SAR 14.31%
- EPS Growth
- TERN N/A
- SAR 33.28
- EPS
- TERN N/A
- SAR 2.49
- Revenue
- TERN N/A
- SAR $154,793,533.00
- Revenue This Year
- TERN N/A
- SAR $6.07
- Revenue Next Year
- TERN N/A
- SAR N/A
- P/E Ratio
- TERN N/A
- SAR $9.33
- Revenue Growth
- TERN N/A
- SAR 11.52
- 52 Week Low
- TERN $1.87
- SAR $21.10
- 52 Week High
- TERN $11.40
- SAR $26.49
- Technical
- Relative Strength Index (RSI)
- TERN 49.80
- SAR 46.21
- Support Level
- TERN $2.22
- SAR $22.60
- Resistance Level
- TERN $2.43
- SAR $23.54
- Average True Range (ATR)
- TERN 0.26
- SAR 0.93
- MACD
- TERN 0.08
- SAR 0.00
- Stochastic Oscillator
- TERN 83.25
- SAR 49.78
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.